Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.

Journal of immunology (Baltimore, Md. : 1950) - 1 May 1998

Raju R, Zhan W Z, Karachunski P, Conti-Fine B, Sieck G C, David C

Abstract excerpt

Studies in myasthenia gravis (MG) patients demonstrate that polymorphism at the HLA-DQ locus influences the development of MG. Several studies using the mouse models also demonstrate the influence of class II molecules, especially the H2-A, which is the mouse homologue of HLA-DQ, in experimental autoimmune myasthenia gravis (EAMG). We used transgenic mice expressing two different DQ molecules, DQ8...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to HLA-DQ Antigens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mice, Transgenic

Share to Myasthenia Gravis

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 9574516

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.PMID 9574516Read ↗

Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.Semantic proximity Read ↗

Molecular immunopathogenesis of myasthenia gravis using MHC class II mutant and transgenic mice.Semantic proximity Read ↗

Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease.Semantic proximity Read ↗

Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis.Semantic proximity Read ↗

Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations.Semantic proximity Read ↗

HLA class II transgenic mice as models of human diseasesSemantic proximity Read ↗

Acetylcholine receptor peptide recognition in HLA DR3-transgenic mice: in vivo responses correlate with MHC-peptide binding.Semantic proximity Read ↗

Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.Semantic proximity Read ↗

Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.Semantic proximity Read ↗

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.Semantic proximity Read ↗

HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.